A two-year study to assess the efficacy, safety, and tolerability of taranabant in obese patients: 52 week results

被引：0
|
作者：
Moreno, M. [1 ]
Gantz, I. [2 ]
Erondu, N. [2 ]
Suryawanshi, S. [2 ]
Musser, B. [2 ]
Nayee, J. [2 ]
Johnson-Levonas, A. O. [2 ]
Heymsfield, S. [2 ]
Amatruda, J. [2 ]
机构：
[1] Univ Catolica Chile, Fac Med, Dept Nutr Diabet & Metab, Santiago, Chile
[2] Merck Res Labs, Rahway, NJ USA
来源：
CIRCULATION | 2008年 / 118卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E415 / E415
页数：1
相关论文
共 50 条
  • [21] VAGUS NERVE STIMULATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: TWO-YEAR SAFETY AND EFFICACY
    Koopman, F. A.
    Musters, A.
    Backer, M. J.
    Gerlag, D.
    Miljko, S.
    Grazio, S.
    Sokolovic, S.
    Levine, Y. A.
    Chernoff, D.
    de Vries, N.
    Tak, P. -P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 981 - 982
  • [22] Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study
    Hsieh, MH
    Chan, P
    Sue, YM
    Liu, JC
    Liang, TH
    Huang, TY
    Tomlinson, B
    Sum, MS
    Kao, PF
    Chen, YJ
    CLINICAL THERAPEUTICS, 2003, 25 (11) : 2797 - 2808
  • [23] A two-year long-term efficacy and safety study of oxcarbazepine in children
    Glauser, TA
    Sachdeo, R
    Bebin, M
    Wheless, J
    D'Souza, J
    ANNALS OF NEUROLOGY, 2002, 52 (03) : S141 - S141
  • [24] A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
    Gopal, S.
    Vijapurkar, U.
    Lim, P.
    Morozova, M.
    Eerdekens, M.
    Hough, D.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (05) : 685 - 697
  • [25] The TOPOS study: Safety and efficacy of an oblique common iliac vein stent in patients with post-thrombotic syndrome - two-year results of the TOPOS study
    Sebastian, Tim
    Barco, Stefano
    Voci, Davide
    Lichtenberg, Michael
    Schlager, Oliver
    Jalaie, Houman
    de Graaf, Rick
    Erbel, Christian
    Massmann, Alexander
    Schindewolf, Marc
    Spirk, David
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2024, 53 (03) : 217 - 224
  • [26] Efficacy and Safety of Filgotinib in Methotrexate-Naive Patients with Rheumatoid Arthritis: 52-Week Results
    Westhovens, Rene
    Rigby, William F. C.
    van der Heijde, Desiree
    Ching, Daniel W. T.
    Stohl, William
    Kay, Jonathan
    Chopra, Arvind
    Bartok, Beatrix
    Matzkies, Franziska
    Yin, Zhaoyu
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Mozaffarian, Neelufar
    Messina, Osvaldo Daniel
    Landewe, Robert
    Atsumi, Tatsuya
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [27] Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: 52-Week Results
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Simon-Campos, J-Abraham
    Baraf, Herbert S.
    Kumar, Uma
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Mozaffarian, Neelufar
    Landewe, Robert
    Bae, Sang-Cheol
    Keystone, Edward C.
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [28] Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study
    Wong, Tien Yin
    Ogura, Yuichiro
    Lee, Won Ki
    Iida, Tmohiro
    Chen, Shih-Jen
    Mitchell, Paul
    Cheung, Chui Ming Gemmy
    Zhang, Zhongqi
    Leal, Sergio
    Ishibashi, Tatsuro
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 204 : 80 - 89
  • [29] Two-year efficacy and tolerability of intermittent intravenous ibandronate injections in postmenopausal osteoporosis: the DIVA study.
    Emkey, R
    Zaidi, V
    Lewiecki, EM
    Burdeska, A
    Mairon, N
    Rowell, L
    Eisman, JA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4060 - 4060
  • [30] Long-term efficacy, safety, tolerability and quality of life with fingolimod treatment in patients with multiple sclerosis in real-world settings in France: VIRGILE two-year results
    Lebrun-Frenay, C.
    Papeix, C.
    Kobelt, G.
    Visy, J-M.
    Coustans, M.
    Debouverie, M.
    Lamy, F.
    Chouette, I.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 904 - 904
12345